Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement
Sign Up to like & getrecommendations! Published in 2019 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-019-0436-1
Abstract: Myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 (FGFR1) rearrangement are rare hematological malignancies. In the 2016 World Health Organization classification, they are listed in myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB,… read more here.
Keywords: fgfr1 rearrangement; lymphoid neoplasms; neoplasms fgfr1; fgfr1 ... See more keywords